June 5, 2025 | Patient involvement, Trial Design, clinical trials, insight, patient engagement
Explore how Cuttsy+Cuttsy and ISPEP are spotlighting patient engagement in clinical trials through a new global report.

Cuttsy+Cuttsy, the original patient communications agency, in partnership with the International Society for Patient Engagement Professionals (ISPEP), is proud to announce the upcoming release of their latest report, offering a 360-degree view into patient engagement in clinical trials, both at recruitment stage and during their time participating in a trial.
Based on extensive global research with over 700 clinical trial patients, as well as insights from the specialist Cuttsy+Cuttsy team alongside industry leaders, the report provides a comprehensive analysis of patient experiences. It sheds light on their motivations, emotional and psychological responses, effectiveness of support materials, and need for clear communication during clinical trials. By gathering feedback from an international audience, the findings offer actionable strategies to enhance patient satisfaction, trial completion rates, and overall study success on a global stage.
“Too often, the patient voice is acknowledged in theory but overlooked in practice,” said Caroline Benson, Co-Founder of Cuttsy+Cuttsy. “This report is about more than metrics; it’s about truly listening to what patients experience and need. When we design trials around real people, not just protocols, everyone wins.”
Alongside ISPEP’s aim to amplify the patient voice across medicine development, this report exemplifies Cuttsy+Cuttsy’s mission to empower the healthcare industry with data-driven tools that advance patient-centric approaches to clinical research.
This content was provided by Cuttsy + Cuttsy
Company Details
Latest Content from Cuttsy + Cuttsy
Explore how pharma can help patients and patient organisations prepare for meaningful involvement in EU HTA without shaping their contribution.
Explore why involving patients early in Joint Scientific Consultations is critical to shaping the outcomes measured in clinical trials.
Explore why long-term clinical trial engagement is a behavioural challenge, showing how proactive support from site teams can help participants stay connected, confident and committed throughout a study.
Patients are often most honest outside the clinic—revealing vital insights that can help clinical trial teams build trust, improve participation and collect better data.
Patient-relevant outcomes sit at the heart of the EU HTA reforms, but ensuring they reflect lived experience requires you to look beyond what traditional clinical endpoints measure.
Exploring how empathetic, patient-centred communication can make planned treatment breaks easier to discuss as part of cancer care.
The EU HTA reforms give patients a formal role in assessing new medicines, but meaningful involvement requires more than simply offering them a seat at the table.
As clinical trials accelerate, clear, accessible consent is essential to help participants understand, engage with and remain in a study.
Older trial participants aren’t rejecting digital technology — they’re rejecting poorly designed, inaccessible experiences that make participation harder.
Key takeaways from the Patient Centricity and Engagement conference, exploring how trust, inclusion and meaningful partnership can help turn patient engagement from intention into action.
